scholarly article | Q13442814 |
P50 | author | Şevket Özkaya | Q59823287 |
P2093 | author name string | Serhat Findik | |
Atilla Guven Atici | |||
P2860 | cites work | Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 |
Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. | Q35881535 | ||
Exacerbation rate, health status and mortality in COPD--a review of potential interventions | Q37236165 | ||
Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease | Q81241524 | ||
The economic burden of COPD. | Q40778466 | ||
Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands | Q40785861 | ||
Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema | Q41732648 | ||
The impact of COPD on lung health worldwide: epidemiology and incidence | Q47685973 | ||
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. | Q51659807 | ||
The costs of exacerbations in chronic obstructive pulmonary disease (COPD). | Q51703317 | ||
Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. | Q52880775 | ||
Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD | Q57778388 | ||
What is the cost to employers of direct medical care for chronic obstructive pulmonary disease? | Q64129101 | ||
The necessary length of hospital stay for chronic pulmonary disease | Q67989944 | ||
Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease | Q71588560 | ||
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) | Q71718436 | ||
The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991 | Q73718003 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
hospitalization | Q3140971 | ||
P304 | page(s) | 15-18 | |
P577 | publication date | 2011-01-17 | |
P1433 | published in | ClinicoEconomics and Outcomes Research | Q5133862 |
P1476 | title | The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease | |
P478 | volume | 3 |
Q36025745 | Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease |
Q37485333 | Clinical factors and comorbidities affecting the cost of hospital-treated COPD. |
Q92861423 | Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China |
Q37365503 | Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities |
Q37682807 | Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review |
Q57815419 | Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data |
Q38089196 | Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease. |
Q41400495 | Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns |
Q38621350 | Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. |
Q92059873 | Serum β2-Microglobulin is Associated with Mortality in Hospitalized Patients with Exacerbated Chronic Obstructive Pulmonary Disease |
Q38348464 | Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease |
Q52564986 | Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study. |